Publication | Closed Access

Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial

Final ResultsBreast OncologyOncologyLiposomal Doxorubicin ToleranceMedicineCancer ManagementClinical TrialsBreast CancerPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyGeriatric Risk FactorsHealth Sciences